Home LiteratureArticle Details
PMID: 11435333 Published · ppublish English Journal Article

Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease.

Circulation ·Vol. 104 ·No. 1 ·2001-07-03 ·Pages 25-31

Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, Schlumberger W, Meyer J, AutoGene Investigators

Abstract

The number of infectious pathogens to which an individual has been exposed (infectious burden) may correlate with coronary artery disease (CAD). In a prospective study, we evaluated the effect of 8 pathogens and the aggregate pathogen burden on the risk for future fatal cardiac events among patients with angiographically documented CAD. Methods and Results-In 1018 patients, IgG or IgA antibodies to herpes simplex virus types 1 and 2, cytomegalovirus, Epstein-Barr virus, Haemophilus influenzae, Chlamydia pneumoniae, Mycoplasma pneumoniae, and Helicobacter pylori were determined. Moreover, highly sensitive C-reactive protein was measured. Follow-up information on cardiovascular events was obtained (mean 3.1 years, maximum 4.3 years). Seropositivities to Epstein-Barr virus (P=0.001), H pylori (P=0.002), and herpes simplex virus type 2 (P=0.045) were independently associated with the future risk of cardiovascular death. An increasing number for pathogen burden was significantly predictive of the long-term prognosis (P<0.0001). Infectious burden divided into 0 to 3, 4 or 5, and 6 to 8 seropositivities was associated with an increasing mortality of 3.7%, 7.2%, and 12.6%, respectively. Patients seropositive to >5 pathogens compared with those seropositive to <4 pathogens had a 5.1 (1.4 to 18.3) higher risk of future cardiac death. This result was mainly driven by the pathogen burden of seropositivities to Herpesviridae (P<0.0001). The prognostic impact of total or viral pathogen burden was independent of the C-reactive protein level. These results support the hypothesis that the number of infectious pathogens to which an individual has been exposed independently contributes to the long-term prognosis in patients with documented CAD.

MeSH Terms
Antibodies, Bacterial/blood Antibodies, Viral/blood Bacterial Infections/diagnosis,epidemiology,immunology C-Reactive Protein/metabolism Chlamydophila pneumoniae/immunology Comorbidity Coronary Disease/diagnosis,epidemiology,immunology,microbiology Cytomegalovirus/immunology Female Follow-Up Studies Haemophilus influenzae/immunology Helicobacter pylori/immunology Herpesvirus 1, Human/immunology Herpesvirus 2, Human/immunology Herpesvirus 4, Human/immunology Humans Immunoglobulin G/blood Male Middle Aged Mycoplasma pneumoniae/immunology Odds Ratio Prognosis Risk Assessment Seroepidemiologic Studies Virus Diseases/diagnosis,epidemiology,immunology
Chemicals
Antibodies, Bacterial Antibodies, Viral Immunoglobulin G C-Reactive Protein
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Rupprecht H J
Department of Medicine II , Johannes Gutenberg University Mainz, Mainz, [email protected]
Blankenberg S
Bickel C
Rippin G
Hafner G
Prellwitz W
Schlumberger W
Meyer J
AutoGene Investigators
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
1524-4539
Published
2001-07-03
Pages
25-31
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]